Pre Next

[1] MENG Yuan?ZHAO Wenjing?WANG Yu?WANG Yuefen?CUI Fangqiang WANG Mengdi ZHANG Kang SUN Xueyan LI Jialin,.Interpretation of Guidelines for Diagnosis and Treatment of Combination of Disease and Syndrome for Diabetes Kidney Disease [J]. Modern Traditional Chinese Medicine, 2023, (01): 19-23. [doi: 10.13424/j.cnki.mtcm.2023.01.004]

Copy

Interpretation of Guidelines for Diagnosis and Treatment of Combination of Disease and Syndrome for Diabetes Kidney Disease

Modern Traditional Chinese Medicine[ISSN: 1006-6977/ CN: 61-1281/TN] Volumes & Issues: 2023 01 pagination: 19-23 Column: Publication date: 2023-01-20

Article number:: 1672-0571(2023)01-0019-05

Author(s):: MENG Yuan?ZHAO Wenjing?WANG Yu?WANG Yuefen?CUI Fangqiang WANG Mengdi ZHANG Kang SUN Xueyan LI Jialin; Department of Nephrology，Beijing Hospital of Chinese Medicine， Capital Medical University，Beijing 100010,China

Keywords:: Diabetes kidney disease; Chinese medicine; Combination of disease and syndrome; Clinical practice guideline; Guideline interpretation

ZTFLH:: R256.5

DOI:: 10.13424/j.cnki.mtcm.2023.01.004

Code:: A??

Abstract:: Guidelines for Diagnosis and Treatment of Combination of Disease and Syndrome for Diabetes Kidney Disease has formulated a diagnosis and treatment guide for diabetes kidney disease (DKD) based on the symptom indicators of DKD，western medicine staging and the combination of TCM disease and syndrome，proposed a diagnosis and treatment path with disease and syndrome integration of DKD，highlighted the characteristics of TCM，and now interprets the updated contents of the guide such as diagnosis，treatment and management.

References:

［1］TNNIES T,RATHMANN W,HOYER A,et al.Quantifying the underestimation of projected global diabetes prevalence by the International Diabetes Federation (IDF) Diabetes Atlas［J］.BMJ Open Diabetes Res Care,2021,9(1):e002122.
［2］HOU JH,ZHU HX,ZHOU ML,et al.Changes in the spectrum of kidney diseases：an analysis of 40,759 biopsy-proven cases from 2003 to 2014 in China［J］.Kidney Dis (Basel),2018,4(1):10-19.
［3］中华医学会肾脏病学分会专家组.糖尿病肾脏疾病临床诊疗中国指南［J］.中华肾脏病杂志,2021,37(3):255-304.
［4］WANG ZQ,Hoy WE.Diabetes and lifetimerisk of ESRD in high-risk remote-dwelling Australian Aboriginal people：a 20-year cohort study.Am J Kidney Dis
［J］.2013,62(4):845-856.
［5］de Boer IH,Gao X,Cleary PA,et al.Albuminuria Changes and Cardiovascular and Renal Outcomes in Type 1 Diabetes：The DCCT/EDIC Study.Clin J Am Soc Nephrol［J］.2016,11(11):1969-1977.
［6］MACLSAAC RJ,TSALAMANDRIS C,PANAGIOTOPOULOS S,et al.Nonalbuminuric renal insufficiency in type 2 diabetes［J］.Diabetes Care,2004,27(1):195-200.
［7］高彦彬,刘铜华,李平.糖尿病肾病中医防治指南［J］.中国中医药现代远程教育,2011,9(4):151-153.
［8］余江毅.糖尿病肾病中西医结合防治专家共识(2019)［C］//中国中西医结合学会内分泌专业委员会.第十二次全国中西医结合内分泌代谢病学术大会暨糖尿病、甲状腺疾病高峰论坛论文资料汇编.沈阳：中国中西医结合学会内分泌专业委员会,2019:7.
［9］STEVENS PE,LEVIN A,Kidney Disease：Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members.Evaluation and management of chronic kidney disease：synopsis of the kidney disease：improving global outcomes 2012 clinical practice guideline［J］.nn Intern Med.2013,158(11):825-830.
［10］刘仪红,田浩.黄芪治疗糖尿病肾病的系统评价［J］.中国循证医学杂志,2007.7 (10):715-727.
［11］徐进,蒋春波.中药黄芪治肾病“机理”说［J］.陕西中医药大学学报,2022,45(2):127-131.
［12］陈仁慈,项洁琼,陈洪宇.冬虫夏草治疗糖尿病肾病疗效的系统评价［J］.中国中西医结合肾病杂志,2017,18(4):340-344.
［13］王琳琳,冯佳莉,刘俊芬,等.丹参多酚酸盐在糖尿病肾病治疗中的临床研究［J］.中国医院药学杂志,2018,38 (6):654-661.
［14］李会芳,程生辉,赵换.丹参注射液辅助治疗糖尿病肾病有效性及安全性的系统评价［J］.中国实验方剂学杂志,2013,19 (6):353-358.
［15］王朝,蒋莉莉,施莉莉,等.水蛭配合西药治疗糖尿病肾病及对尿微量白蛋白和内皮功能的影响［J］.陕西中医,2014,35 (10):1306-1308.
［16］刘吉尧,徐霜霜,曾海文,等.水蛭对糖尿病肾病的疗效及安全性的Meta分析［J］.实用中医内科杂志,2021,35 (5):137-139,157.
［17］王红纲,赵振霄,刘丽秋,等.大黄对糖尿病肾病治疗作用的临床研究［J］.北京中医药大学学报,1996,19(5):36-37.
［18］黄颖,吴思敏,赵玲.大黄治疗糖尿病肾病有效性的系统评价［J］.黑龙江中医药,2021,50 (2):86-89.
［19］SHI L,FENG L,ZHANG M,et al.Abelmoschus manihot for diabetic nephropathy：a systematic review and meta-analysis［J］.Evid Based Complement Alternat Med,2019,2019：9679234.
［20］赵豫梅,吴于滨,宋滇平.渴络欣胶囊联合ARB类药物治疗糖尿病肾病有效性及安全性的系统评价［J］.中国中西医结合肾病杂志,2017.18 (7):610-613.
［21］刘红,孙伟,顾刘宝,等.黄葵胶囊联合ACEI或ARB类药物治疗糖尿病肾病的Meta分析［J］.中华中医药杂志,2015,30 (5):1712-1718.
［22］童静,李鹏飞.黄葵胶囊联合ACEI/ARB类药物治疗慢性肾炎疗效及安全性Meta分析［J］.现代中医药,2020,40(5):29-44.
［23］王海焱,刘铜华.参芪降糖颗粒治疗糖尿病肾病Meta分析［J］.世界科学技术-中医药现代化,2015,17(12):2608-2613.
［24］李翠萍,王倩,顾叶文,等.益肾化湿颗粒治疗糖尿病肾病有效性与安全性的Meta分析［J］.实用医学杂志,2020,36 (5):682-688.
［25］赵怡蕊,陈曦,牛肖媛,等.国医大师张大宁教授巧用炭剂治肾病［J］.世界中医药,2015,10(12):1906-1908.
［26］王国柱,裴瑞霞,江海身,等.时振声中医世家经验辑要［M］.西安：陕西科学技术出版社,2004:248-249.
［27］赵进喜,王耀献.吕仁和临床经验集［M］.北京:人民军医出版社,2009:192-195.
［28］谷绍飞.浅析国医大师李济仁教授辨治糖尿病肾病经验［C］//中华中医药学会糖尿病分会.2019首届全国中青年中医糖尿病论坛.开封:中华中医药学会糖尿病分会,2019:79-83.
［29］严倩华,邹燕勤.国医大师邹燕勤教授从脾肾论治糖尿病肾病［J］.南京中医药大学学报,2018,34 (2):109-111.
［30］许海燕,王旭.中药灌肠治疗糖尿病肾病的有效性及安全性系统评价［J］.南京中医药大学学报,2015,31(4):392-396.
［31］姜秀云.中药灌肠治疗糖尿病晚期肾病的疗效观察［J］.中国全科医学,2005,8 (4)：321-322.

Memo

基金项目：北京市自然科学基金面上项目（7222271）；首都卫生发展科研专项项目（202241162）；北京市中医药科技发展资金项目（JJ202046）

Last Update: 2023-01-20